STOCK TITAN

SelectQuote (SLQT) 10-K Filings

SLQT NYSE

Here are the 10-K annual reports from SelectQuote, Inc. (SLQT) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow SLQT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SLQT filings page.

Rhea-AI Summary

SelectQuote, Inc. (SLQT) describes a technology-enabled, direct-to-consumer platform that distributes senior health, life, and auto & home insurance while expanding into healthcare services, including its SelectRx pharmacy, Healthcare Select, and chronic care management offerings. The company emphasizes use of AI and machine learning across lead acquisition, agent routing, contact-center voice technology, and customer lifecycle management to maximize lifetime value of commissions.

SelectQuote’s strategy is to prioritize higher-growth senior and healthcare services and de-emphasize Auto & Home, leveraging a large senior customer base, proprietary CRM (SelectCare) and related tools to cross-sell insurance and health services. As of June 30, 2026, SelectRx served over 109,000 active members, with facilities able to serve more than 200,000. Revenue is concentrated: for 2026, entities owned by UHC, Humana, and Aetna represented 39%, 13%, and 12% of total revenue. Senior segment revenue contributed 36% of total revenue in 2026, versus 39% in 2025 and 50% in 2024.

The company highlights extensive regulatory exposure across insurance, Medicare, pharmacy, data privacy, and telemarketing, and notes that its pharmacy and healthcare units are subject to additional healthcare fraud, abuse, and provider regulations. SelectQuote discloses significant reliance on a small group of carrier partners and acknowledges litigation risk, including a Department of Justice action alleging violations of the False Claims Act against it and other industry participants.

Rhea-AI Summary

SelectQuote, Inc. reported strategic growth in its healthcare and pharmacy businesses while managing leverage and shifting its distribution mix. Pharmacy revenue rose materially, increasing by $263.9 million (57%) in fiscal 2025 driven by a 31% increase in SelectRx members. Commission and other services revenue declined $59.1 million (7%), led by lower Senior commissions and a 4% decrease in approved policies. The company processed over 1.05 million assisted disclaimers with voice AI and saved over 4.7 million minutes of agent time through automation. SelectQuote reduced total debt to $385.1 million at June 30, 2025 (from $683.3 million prior year) after securitization and debt repayments, and held $37.1 million of cash and equivalents. The business remains concentrated: carriers owned by UHC, Aetna and Humana accounted for 37%, 15%, and 11% of revenue in 2025. The company emphasizes maximizing lifetime value (LTV) through AI-driven lead scoring, agent routing and post-sale retention efforts.